TIDMMEDG 
 
Medgenics, Inc. 
                         ('Medgenics' or the 'Company') 
 
                                 Issue of Equity 
 
7 October 2009 
 
The  Company announces that on 6 October 2009 it completed a private placing  to 
raise  GBP265,200  and a Board resolution was passed to issue and allot  4,420,000 
common  shares of US  $0.0001 par value each ("Common Shares") conditional  upon 
admission to trading on AIM.  The new Common Shares were issued at a price of  6 
pence  per  Common  Share.  Application has now been made to  the  London  Stock 
Exchange  for  the New Common Shares to be admitted to trading on AIM.  Dealings 
are expected to commence at 8.00 a.m. on 12 October 2009. 
 
Following the admission to trading of the new Common Shares, the Company's total 
issued share capital will be 122,174,028* Common Shares of US $0.0001 each,  the 
percentage of AIM Securities not in public hands will be 29.4%*. 
 
Note 
*  Excluding any Common Shares issued pursuant to the block admission between  4 
June 2009 and the date of this announcement. 
 
For further information, contact: 
 
Medgenics, Inc.                                                +972 4 902 8900 
Dr. Andrew L. Pearlman 
 
Grayling (Public Relations)                                    +44 207 638 9571 
Dr. Mark Swallow 
Jonathan Shillington (Global Consulting Group) 
 
Blomfield Corporate Finance (Nomad)                            +44 207 489 4500 
James Pinner 
Alan MacKenzie 
 
SVS Securities plc (Broker)                                    +44 207 638 5600 
Peter Manfield or 
Ian Callaway
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Medgenics(Regs) Charts.
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Medgenics(Regs) Charts.